NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Central Nervous System Agent


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Local health investigation sheds light on gastroschisis birth defect
2009 NOV 28 ... Pediatrics, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Bronchodilator, Central Nervous System Agent, Central Nervous System Stimulant, Clinical Trial Research, Cocaine, Community Health, ...
Subject: University of Nevada, Reno
Price: $3.00
*
New tuberculosis data have been reported by researchers at Hanyang University
2009 NOV 23 ... Therapy, Treatment, Hanyang University. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... Release Assay to Detect Hidden Tuberculosis Infection During Anti-Tumor Necrosis Factor Agent Trial. Journal of Rheumatology, 2009;36(10):2158-2163). Additional ...
Subject: Tuberculosis
Price: $3.00
*
News brief: Antitumor activity of nutlin-3 in neuroblastoma with wild-type p53
2009 NOV 23 ... of the National Cancer Institute. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... tumor that often has a poor outcome). Oral administration of nutlin-3 as a single agent reduced tumor growth and metastasis. "These findings support the ...
Subject: Journal of the National Cancer Institute
Price: $3.00
*
Novartis to Acquire Majority Stake in Hard to Treat Diseases' HTDS.PK China Subsidiary H1N1 Vaccine Partner for US$125 Million
2009 NOV 23 ... drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. To ... HTDS' Chinese subsidiary, Mellow Hope, is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical for International marketing and sales. Zhejiang ...
Subject: Hard to Treat Diseases HTDS
Price: $3.00
*
Recent findings from Kyoto University, Department of Respiratory Medicine highlight research in pneumonia therapy
2009 NOV 23 ... serogroups (OR 7.2; 95% CI 2.5-23.7), prevalence of rlrA (OR 12.6; 95% CI 3.6-59.7) and central nervous system-related disorders (OR 7.7; 95% CI 1.8-48.4) were independently associated ... collected from May 2003 through October 2004. The strains were tested for antimicrobial agent susceptibility, serotype and genotype by multilocus sequence typing (MLST) and the ...
Subject: Pneumonia Therapy
Price: $3.00
*
Report summarizes schizophrenia study findings from Tel-Aviv University
2009 NOV 23 ... Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Antipsychotic, Central Nervous System Stimulant, Clozapine, Dopamine, Drugs, Endocrinology, Estradiol, ...
Subject: Schizophrenia
Price: $3.00
*
Reports from M.B. Haffey et al highlight recent research in pharmacokinetics
2009 NOV 23 ... Inhibitor, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Amphetamine, Central Nervous System Stimulant, Dopamine, Drugs, Lisdexamfetamine Dimesylate, Omeprazole, ... USA. Keywords: City:Wayne, State:PA, Country:United States, Adrenergic Agent, Adrenergic Uptake Inhibitor, Adverse Drug Effect, Adverse Drug Event, Adverse Drug ...
Subject: Pharmacokinetics
Price: $3.00
*
Reports from Technion, Department of Pharmacology advance knowledge in life sciences
2009 NOV 23 ... Biotechnology, Genomics, Genetics, Selegiline, Antidyskinetic, Antiparkinson, Central Nervous System Agent, Dopaminergic, Neuroprotective Agent, Neurotoxins. This article was ...
Subject: Life Sciences
View Free
Daily News
Article
Reports from W. Adams and colleagues advance knowledge in schizophrenia
2009 NOV 23 ... Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Analgesic, Anesthetic, Central Nervous System Stimulant, Cocaine, Dopamine, Ketamine, Pharmaceuticals, Psychiatry, ...
Subject: Schizophrenia
Price: $3.00
*
Reports on life sciences findings from University of Chile provide new insights
2009 NOV 23 ... Epinephrine, Pain Medicine, Analgesia. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... a long-acting local anesthetic would improve the management of pain, but no such agent is yet available for clinical use." "The aim of this study is to evaluate ...
Subject: Life Sciences
Price: $3.00
*
Research from Patras University provides new data on unstable angina
2009 NOV 23 ... Unstable Angina, Patras University. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... Cardiovascular, Clopidogrel, Creatine, Dietary Supplement, Enzymes, Fibrinolytic Agent, Heart Attack, Infarction, Kinase, Micronutrient, Myocardial Infarction, Platelet ...
Subject: Unstable Angina
Price: $3.00
*
Research from University of Utrecht yields new findings on psychopharmacology
2009 NOV 28 ... Life Sciences, Amphetamine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Central Nervous System Stimulant, Dopamine, Haloperidol, Pharmaceuticals, Drugs, Therapy, ...
Subject: Psychopharmacology
Price: $3.00
*
Research in the area of schizophrenia therapy reported from Polish Academy of Sciences, Pharmacology Department
2009 NOV 23 ... activity," investigators in Krakow, Poland report. "It is well known that central nervous system stimulants such as: amphetamine, cocaine, phencyclidine, and selective ... Keywords: Poland, Krakow, Schizophrenia Therapy, Addiction Medicine, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Antipsychotic, Behavior, Biochemical, Central ...
Subject: Schizophrenia Therapy
Price: $3.00
*
Research results from Michigan State University update knowledge of proteomics
2009 NOV 23 ... Country:United States, Adrenergic Agent, Adrenergic Uptake Inhibitor, Amphetamine, Central Nervous System Stimulant, Cocaine, Dopamine, Drugs, Estradiol, Hormones, Peptide, ...
Subject: Proteomics
Price: $3.00
*
Studies from Can-Fite BioPharma yield new data on arthritis
2009 NOV 23 ... Therapy, Treatment, Can-Fite BioPharma. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... A(3) adenosine receptor agonist CF101 was recently defined as a potent antiinflammatory agent for the treatment of RA." "The purpose of this study was to examine the ...
Subject: Arthritis
View Free
Daily News
Article
Studies from Weizmann Institute of Science, Department of Immunology further understanding of multiple sclerosis therapy
2009 NOV 23 ... progression. Specific treatment strategies should thus target the injury sites at the central nervous system (CNS) to interfere with both neuroinflammation and neurodegeneration," ... sclerosis, was shown earlier to act as an anti-inflammatory and immunomodulatory agent. In this mini-review its effect on neuroprotection, neurogenesis and on the ...
Subject: Multiple Sclerosis Therapy
Price: $3.00
*
Study data from Vanderbilt University update understanding of headache and migraine
2009 NOV 23 ... Women's Health, Vanderbilt University. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... Frovatriptan, Gynecology, Headache, Menstruation, Migraine, Neurology, Vasoconstrictor Agent, Women's Health, Vanderbilt University. This article was prepared by Pain ...
Subject: Headache and Migraine
Price: $3.00
*
Total Nutraceutical Solutions Research Data Reveals Ability to Control Oxidative Stress
2009 NOV 23 ... Vitamin D2, Vitamins (Vitamin D) This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... was dramatically induced in the Drosophila melanogaster fruitfly model by the toxic agent, Paraquat, and the end-point of death was evaluated. The proprietary formula consisted ...
Subject: Total Nutraceutical Solutions, Inc.
Price: $3.00
*
U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
2009 NOV 23 ... University of Michigan Health System. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... in rodents with nerve damage caused by trauma or diabetes. A gene transfer vector is an agent used to carry genes into cells. The newly awarded grant from the Department ...
Subject: Herpes Simplex
Price: $3.00
*
VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
2009 NOV 23 ... Therapy, Treatment, VisEn Medical Inc. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2009, Pain & ... medicine, announced the commercial launch of its new Cat B 750 FAST™ imaging agent for measuring and monitoring cathepsin B activity associated with disease progression ...
Subject: Disease Progression
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login